Put Options

18 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $976,650 - $1.21 Million
38,300 Added 41.59%
130,400 $3.73 Million
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $2.24 Million - $2.87 Million
81,000 Added 729.73%
92,100 $2.69 Million
Q4 2023

Feb 14, 2024

BUY
$26.32 - $34.31 $289,520 - $377,410
11,000 Added 11000.0%
11,100 $374,000
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $3,068 - $4,009
100 New
100 $3,000
Q4 2022

Feb 14, 2023

SELL
$38.19 - $57.45 $3,819 - $5,745
-100 Reduced 5.56%
1,700 $65,000
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $87,108 - $100,113
1,700 Added 1700.0%
1,800 $96,000
Q2 2022

Aug 08, 2022

SELL
$51.49 - $81.64 $164,768 - $261,248
-3,200 Reduced 96.97%
100 $6,000
Q1 2022

May 16, 2022

BUY
$60.03 - $76.49 $36,018 - $45,894
600 Added 22.22%
3,300 $252,000
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $129,519 - $167,967
2,700 New
2,700 $162,000
Q3 2021

Nov 15, 2021

SELL
$54.64 - $61.3 $360,624 - $404,580
-6,600 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$59.18 - $69.99 $390,588 - $461,933
6,600 New
6,600 $400,000
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $153,360 - $273,780
-5,400 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$36.31 - $46.83 $196,074 - $252,882
5,400 New
5,400 $245,000
Q3 2019

Nov 14, 2019

SELL
$35.66 - $44.99 $188,997 - $238,447
-5,300 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$36.57 - $47.97 $193,821 - $254,241
5,300 New
5,300 $230,000
Q1 2019

May 15, 2019

SELL
$36.47 - $42.17 $32,823 - $37,953
-900 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$41.31 - $52.16 $1.77 Million - $2.24 Million
-42,900 Reduced 97.95%
900 $39,000
Q3 2018

Nov 14, 2018

BUY
$32.85 - $52.0 $1.44 Million - $2.28 Million
43,800 New
43,800 $2.15 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.22B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.